Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

Research

Effect of single versus multistrain probiotic in extremely preterm infants: a randomised trial

Evidence indicates that multistrain probiotics benefit preterm infants more than single-strain (SS) probiotics. We assessed the effects of SS versus triple-strain (TS) probiotic supplementation (PS) in extremely preterm (EP) infants.

News & Events

Does your school pass the test?

Do you feel your child is well supported by their school when it comes to managing diabetes? If so, our researchers want to hear from you.

News & Events

Free-living CGM Performance Study

Participants are needed for a new study that will test the performance of a new Medtronic sensor with readings from finger-pricks.

News & Events

Frangipani Family Day

Frangipani Family Day is an opportunity for CliniKids to celebrate the families we engage with through our clinical services and research.

Research

The transient value of classifying preschool wheeze into episodic viral wheeze and multiple trigger wheeze

A recently proposed method for classifying preschool wheeze is to describe it as either episodic (viral) wheeze or multiple trigger wheeze.

Research

Evolution of islet autoantibodies in the Environmental Determinants of Islet Autoimmunity (ENDIA) prospective cohort

Islet autoantibodies herald early type 1 diabetes. However, less is known of the evolution of autoantibodies to the islet autoantigen ZnT8. Our primary aim was to characterise the development of islet autoantibodies in a pregnancy-birth at-risk cohort and to provide new knowledge about ZnT8A.

News & Events

Exercise summit wrap up

The Children’s Diabetes Centre recently held summits for young people with Type 1 Diabetes to get their input into the development of new exercise guidelines.

News & Events

Congratulations Centre Researchers

Centre researchers awarded external travel grants to attend international conferences

Research

Prenatal omega-3 LCPUFA and symptoms of allergic disease and sensitization throughout early childhood

Maternal supplementation with 900 mg of ω-3 LCPUFA did not change the progression of IgE-mediated allergic disease symptoms or sensitization